These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
67 related items for PubMed ID: 21084546
1. Evaluation of a novel sputum clearance technique--hydro-acoustic therapy (HAT) in adult patients with cystic fibrosis: a feasibility study. Jarad NA, Powell T, Smith E. Chron Respir Dis; 2010; 7(4):217-27. PubMed ID: 21084546 [Abstract] [Full Text] [Related]
6. Comparative study of PEP mask and Flutter on expectoration in cystic fibrosis patients. Borka P, Gyurkovits K, Bódis J. Acta Physiol Hung; 2012 Sep; 99(3):324-31. PubMed ID: 22982720 [Abstract] [Full Text] [Related]
7. Influence of the Vibralung Acoustical Percussor on pulmonary function and sputum expectoration in individuals with cystic fibrosis. Wheatley CM, Baker SE, Daines CM, Phan H, Martinez MG, Morgan WJ, Snyder EM. Ther Adv Respir Dis; 2018 Sep; 12():1753466618770997. PubMed ID: 29697011 [Abstract] [Full Text] [Related]
8. Effects of treadmill exercise versus Flutter® on respiratory flow and sputum properties in adults with cystic fibrosis: a randomised, controlled, cross-over trial. Dwyer TJ, Zainuldin R, Daviskas E, Bye PT, Alison JA. BMC Pulm Med; 2017 Jan 11; 17(1):14. PubMed ID: 28077104 [Abstract] [Full Text] [Related]
9. Mechanical airway clearance using the frequencer electro-acoustical transducer in cystic fibrosis. Cantin AM, Bacon M, Berthiaume Y. Clin Invest Med; 2006 Jun 11; 29(3):159-65. PubMed ID: 17058435 [Abstract] [Full Text] [Related]
13. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis. Fitzgerald DA, Hilton J, Jepson B, Smith L. Pediatrics; 2005 Oct 11; 116(4):e549-54. PubMed ID: 16147970 [Abstract] [Full Text] [Related]
14. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis. Eng PA, Morton J, Douglass JA, Riedler J, Wilson J, Robertson CF. Pediatr Pulmonol; 1996 Feb 11; 21(2):77-83. PubMed ID: 8882210 [Abstract] [Full Text] [Related]
15. Effects of montelukast treatment on clinical and inflammatory variables in patients with cystic fibrosis. Stelmach I, Korzeniewska A, Stelmach W, Majak P, Grzelewski T, Jerzynska J. Ann Allergy Asthma Immunol; 2005 Oct 11; 95(4):372-80. PubMed ID: 16279568 [Abstract] [Full Text] [Related]
17. Acapella vs. PEP mask therapy: a randomised trial in children with cystic fibrosis during respiratory exacerbation. West K, Wallen M, Follett J. Physiother Theory Pract; 2010 Apr 22; 26(3):143-9. PubMed ID: 20331370 [Abstract] [Full Text] [Related]